Literature DB >> 17661057

[Hazeformation (corneal scarring) after cross-linking therapy in keratoconus].

C I A Herrmann1, T Hammer, G I W Duncker.   

Abstract

The aim of cross-linking therapy is to prevent keratoconus progression and stabilize the present refractive situation. A 41-year-old man was treated with collagen cross-linking in one eye. Postoperatively there were a diffuse subepithelial opacification and a paracentral corneal thinning. This superficial scarring in the sense of a "haze" disappeared only gradually despite intensive therapy.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 17661057     DOI： 10.1007/s00347-007-1568-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


  6 in total

1.  Corneal cross-linking-induced stromal demarcation line.

Authors:  Theo Seiler; Farhad Hafezi
Journal:  Cornea       Date:  2006-10       Impact factor: 2.651

2.  Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study.

Authors:  Aldo Caporossi; Stefano Baiocchi; Cosimo Mazzotta; Claudio Traversi; Tomaso Caporossi
Journal:  J Cataract Refract Surg       Date:  2006-05       Impact factor: 3.351

3.  Conservative treatment of keratoconus by riboflavin-uva-induced cross-linking of corneal collagen: qualitative investigation.

Authors:  C Mazzotta; C Traversi; S Baiocchi; P Sergio; T Caporossi; A Caporossi
Journal:  Eur J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.597

4.  Biochemical studies on human corneal proteoglycans--a comparison of normal and keratoconic eyes.

Authors:  J Wollensak; E Buddecke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

5.  Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans.

Authors:  Cosimo Mazzotta; Angelo Balestrazzi; Claudio Traversi; Stefano Baiocchi; Tomaso Caporossi; Cristina Tommasi; Aldo Caporossi
Journal:  Cornea       Date:  2007-05       Impact factor: 2.651

6.  [Treatment of keratoconus by collagen cross linking].

Authors:  G Wollensak; E Spörl; T Seiler
Journal:  Ophthalmologe       Date:  2003-01       Impact factor: 1.059
  6 in total
  9 in total

1.  [Haze or calcific band keratopathy after crosslinking treatment?].

Authors:  G Wollensak; T Hammer; C I A Herrmann
Journal:  Ophthalmologe       Date:  2008-09       Impact factor: 1.059

2.  Biological and biomechanical responses to traditional epithelium-off and transepithelial riboflavin-UVA CXL techniques in rabbits.

Authors:  Brian K Armstrong; Michelle P Lin; Matthew R Ford; Marcony R Santhiago; Vivek Singh; Gregory H Grossman; Vandana Agrawal; Roy A Sinha; Robert S Butler; William J Dupps; Steven E Wilson
Journal:  J Refract Surg       Date:  2013-05       Impact factor: 3.573

3.  [Corneal scar development after cross-linking in keratoconus].

Authors:  F Raiskup; A Kissner; A Hoyer; E Spörl; L E Pillunat
Journal:  Ophthalmologe       Date:  2010-09       Impact factor: 1.059

4.  Herpetic keratitis after corneal collagen cross-linking with riboflavin and ultraviolet-A for progressive keratoconus.

Authors:  Nilay Yuksel; Kamil Bilgihan; Ahmet M Hondur
Journal:  Int Ophthalmol       Date:  2011-12-03       Impact factor: 2.031

5.  [Collagen cross-linking with riboflavin and UVA light in keratoconus. Results from Dresden].

Authors:  A Hoyer; F Raiskup-Wolf; E Spörl; L E Pillunat
Journal:  Ophthalmologe       Date:  2009-02       Impact factor: 1.059

6.  Effects and adverse events after CXL for keratoconus are independent of age: a 1-year follow-up study.

Authors:  P B Baenninger; L M Bachmann; L Wienecke; C Kaufmann; M A Thiel
Journal:  Eye (Lond)       Date:  2014-03-14       Impact factor: 3.775

7.  Collagen cross-linking: current status and future directions.

Authors:  Marine Hovakimyan; Rudolf F Guthoff; Oliver Stachs
Journal:  J Ophthalmol       Date:  2012-01-12       Impact factor: 1.909

8.  Corneal imaging and densitometry measurements in keratoconus patients to monitor disease progression and treatment outcomes after contact lens or Intacs treatment.

Authors:  Khaled Alzahrani; Cristina Cristian; Sophie Harper; Fiona Carley; Arun Brahma; Debbie Morley; M Chantal Hillarby
Journal:  Clin Ophthalmol       Date:  2018-09-04

9.  Corneal Imaging and Densitometry Measurements in Juvenile and Adult Keratoconus Patients to Evaluate Disease Progression and Treatment Effects After Corneal Cross-Linking.

Authors:  Khaled Alzahrani; Hanan Mofty; Emily Yc Lin; Fiona Carley; Arun Brahma; Debbie Morley; Susmito Biswas; M Chantal Hillarby
Journal:  Clin Optom (Auckl)       Date:  2019-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.